Made with ❤️ by True Sparrow

Bringing you the latest funding data

Relation Therapeutics

Last funding round

Raised
$35,000,000
Round
Seed
Investors
Led by NVentures,DCVC

Funding News (3)

Mar 14 2024financialpost

Startup details

Relation Therapeutics

Relation Therapeutics

Relation Therapeutics is a biotechnology company that discovers and develops transformational medicines using experimental and computational systems. The company's Lab-in-the-Loop approach combines single cell multi-omics directly from patient tissue, functional assays, and machine learning to understand biological processes in human health and disease.
www.relationrx.com
London, United Kingdom
Established in 2019
51-200 People
Healthcare, Drug Discovery and Delivery

Founders

Casey Benjamin Swerner

Casey Benjamin Swerner

Co-founder and COO

London, England, United Kingdom

David Roblin

David Roblin

Chief Executive Officer

London, England, United Kingdom

Investment details

Total Funding
$60,000,000
Raised
$35,000,000
Round
Seed
Investors
NVentures
LEAD
DCVC
LEAD
Khosla Ventures
ARK Investments
Deerfield Management
Magnetic Ventures
Abcam

Funding News (2)

Mar 14 2024BioSpace
Mar 14 2024EIN News

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from United Kingdom

Jul2024
1

3 weeks ago

Natcap raised a $10M Series A from Norinchukin Bank and 6 others
UK-based Natcap provides nature data for assessing risks and opportunities in corporate reporting.
Natcap

Founders

Kathy Willis

In News

Carbon Pulse
2

3 weeks ago

Altrove raised a $4M Pre-Seed led by Contrarian Ventures
London-based Altrove develops sustainable alternatives to critical earth materials.
Altrove

Founders

Thibaud Martin,

Dr. Joonatan Laulainen

In News

Tech.eu
Tech Funding News
Yahoo Tech
StartupNews.fyi
3

3 weeks ago

TaperedPlus raised $7M from Comhar Capital
UK-based TaperedPlus specializes in tech-enabled architectural design services for flat and tapered roof projects.
TaperedPlus

Founders

Robert Vass,

Aman Chahal

In News

Business Up North
4

3 weeks ago

Beacon Therapeutics raised a $170M Series B led by Forbion and 1 other
London-based Beacon Therapeutics develops gene therapies for blinding retinal diseases.
Beacon Therapeutics

Founders

David Fellows

In News

NewsnReleases
DirectorsTalk Interviews
5

3 weeks ago

Trever raised a $2.6M Seed led by TX Ventures and 1 other
Europe-based Trever provides infrastructure for digital asset management to financial institutions.
Trever

Founders

Hans-Jürgen Griesbacher

In News

Tech.eu
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.